Thread by @d_s_thakur

So the DGFT issued a diktat that all cough syrup for export needed to be tested before shipped out because of the public fall out from the deaths of children.

And because we began testing these "for export" medicines, we found that over 50 failed tests for quality
1/n

2/n
Does that not make you wonder what the quality of other medicines, not just cough syrups is that we export? 🤔

Here is an example. Sri Lanka did a retrospective review on withheld and recalled medicines between June 2018 and August 2021

bmchealthservres.biomedcentral.com/articles/10.11…

3/n
And here is what they found:

4/n

5/n
And this:

6/n
Remember, we still dont mandate stability testing for medicines sold in our market. Therefore, we have no idea what percentage of our drug supply actually would pass standard stability tests.

Sri Lanka found that in their retrospective study, 15% failed assay (did not have

7/n
enough API) and 36% had impurities. Shocking. 😱

Maybe the DGFT can mandate compulsory testing of all medicinal products we export so that we would at least know what the extent of the problem is.

Clearly, @CDSCO_INDIA_INF doesnt want to tell us.

Buyer Beware!